|
|
|
| Relationship between β-hCG Levels TNF-α/IL-10 Ratio and Adverse Pregnancy Outcomes in Pregnant Women with Gestational Diabetes Mellitus |
| ZHU Ling, ZENG Lingfang |
| Huangshan People's Hospital, Anhui Huangshan 245000, China |
|
|
|
|
Abstract Objective: To observe the changes of β-human chorionic gonadotropin (β-hCG) and tumor necrosis factor-α (TNF-α)/interleukin-10 (IL-10) ratio in patients with gestational diabetes mellitus (GDM), and to analyze the relationship with adverse pregnancy outcomes.Methods: A total of 102 GDM patients admitted to our hospital from January 2020 to January 2023 were included. The serum levels of β-hCG and the TNF-α/IL-10 ratio were detected, and their association with adverse pregnancy outcomes was analyzed.Results: Serum β-hCG and TNF-α/IL-10 ratio of pregnant women with adverse pregnancy outcomes were significantly higher than those of pregnant women with normal pregnancy outcomes (P<0.05). Univariate analysis showed that history of adverse pregnancy, bacterial vaginosis, age and HbA1c were associated with adverse pregnancy outcomes in GDM patients (P<0.05). Logistic regression analysis indicated that adverse pregnancy history, age, HbA1c, β-hCG, and TNF-α/IL-10 ratio were risk factors for adverse pregnancy outcomes in GDM patients (P<0.05). ROC results suggested that the AUCs of serum β-hCG and TNF-α/IL-10 in evaluating adverse pregnancy outcomes in GDM patients were 0.804 (95%CI: 0.695~0.912) and 0.729 (95%CI: 0.614~0.844) respectively. The AUC of the combination of the two indicators was 0.867 (95%CI: 0.787~0.947) in assessing the adverse pregnancy outcomes, and the sensitivity and specificity under the maximum Youden index were 0.786 and 0.811, respectively.Conclusion: Abnormal increases in serum β-hCG and the TNF-α/IL-10 ratio in GDM pregnant women are associated with adverse pregnancy outcomes, and their combined assessment has a high evaluation value for adverse pregnancy outcomes.
|
|
|
|
|
|
[1] Hannah W,Pradeepa R,Anjana RM,et al.Early gestational diabetes mellitus:an update[J].Assoc Physicians India,2023,71(9):101-103.
[2] Moon JH,Jang HC.Gestational diabetes mellitus:diagnostic approaches and maternal-offspring complications[J].Diabetes Metab,2022,46(1):3-14.
[3] 丁媛媛,陈秀萍,郝东亚,等.血清SHBG、β-HCG、HIF-1α与妊娠期糖尿病及不良妊娠结局的关系分析[J].河北医学,2022,28(12):2022-2026.
[4] Tsakiridis I,Giouleka S,Mamopoulos A,et al.Diagnosis and management of gestational diabetes mellitus:an overview of national and international guidelines[J].Obstet Gynecol Surv,2021,76(6):367-381.
[5] Will JS,Crellin H.Gestational diabetes mellitus:update on screening,diagnosis,and management[J].Am Fam Physician,2023,108(3):249-258.
[6] Abera DA,Larbie C,Abugri J,et al.Prevalence and predictors of gestational diabetes mellitus in sub-saharan africa:a 10-year systematic review[J].Endocrinol Diabetes Metab,2024,7(3):478.
[7] 郭晓,郭战坤,李静.血清胎盘蛋白-13,β-人绒毛膜促性腺激素,分泌型卷曲相关蛋白5及血清胎盘生长因子检测对妊娠期糖尿病不良妊娠结局的诊断价值[J].陕西医学杂志,2023,52(8):1085-1088.
[8] Olmos-Ortiz A,Flores-Espinosa P,Diaz L,et al.Immunoendocrine dysregulation during gestational diabetes mellitus:the central role of the placenta[J].Int Mol Sci,2021,22(15):8087.
[9] Ji Q,Li X,Wang Y,et al.Periostin acts as a bridge between gestational diabetes mellitus (GDM) and chronic inflammation to modulate insulin resistance by modulating PPARα/NF-κB/TNF-α signaling pathway[J].Endocr Metab Immune Disord Drug Targets,2023,23(13):1649-1659.
[10] De Luccia TPB,Ono E,Menon R,et al.The effect of gestational diabetes mellitus on the fetal compartment[J].Reprod Immunol,2021(145):103314.
[11] 许娟娟,刘健,卢晶晶.妊娠期糖尿病患者血清TNF-α/IL-10比值及NLR与产后糖代谢转归的相关性研究[J].中国性科学,2024,33(2):79-84. |
|
|
|
2024, Vol. 30 
